Evidence map›Paper›PMID 37458914›Full record

ArticleBiological trace element research2024

Resveratrol Inhibits Zinc Deficiency-Induced Mitophagy and Exerts Cardiac Cytoprotective Effects.

Pei Wang, Ying Yang, Jiabao Guo, Tingting Ma, Youcheng Hu, Luyao Huang, Yonggui He, Jinkun Xi

Abstract read
PubMed Publisher
In one paragraph

Article in Biological trace element research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Reactivation ofInternational journal of molecular sciences · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Pei WangSchool of Public Health, North China University of Science and Technology, Tangshan, 063000, China.
Ying YangBasic School of Medicine, Hebei Key Laboratory for Chronic Diseases, North China University of Science and Technology, Tangshan, China.
Jiabao GuoClinic School of Medicine, Hebei Key Laboratory of Medical-Industrial Integration Precision Medicine, North China University of Science and Technology, Tangshan, 063000, China.
Tingting MaClinic School of Medicine, Hebei Key Laboratory of Medical-Industrial Integration Precision Medicine, North China University of Science and Technology, Tangshan, 063000, China.
Youcheng HuBasic School of Medicine, Hebei Key Laboratory for Chronic Diseases, North China University of Science and Technology, Tangshan, China.
Luyao HuangBasic School of Medicine, Hebei Key Laboratory for Chronic Diseases, North China University of Science and Technology, Tangshan, China.
Yonggui HeAffiliated Hospital, North China University of Science and Technology, Tangshan, 063000, China. heyonggui-1994@163.com.
Jinkun XiSchool of Public Health, North China University of Science and Technology, Tangshan, 063000, China. jinkunxi@126.com.
North China University of Science and Technology · CN

Funding

Natural Science Foundation of China No.82270303the Natural Science Foundation of Hebei Province H2021209061the Natural Science Foundation of Hebei Province No. H2020209172
6 · The paper itself

Abstract

Resveratrol (Res) possesses various beneficial effects, including cardioprotective, anti-inflammatory, anti-aging, and antioxidant properties. However, the precise mechanism underlying these effects remains unclear. Here we investigated the protective effects of resveratrol on cardiomyocytes, focusing on the role of Zn

Indexed as

AMP-Activated Protein KinasesEthylenediaminesMitophagyMyocytes, CardiacResveratrolUbiquitin-Protein LigasesZincAMP-Activated Protein KinasesEthylenediaminesN,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamineResveratrolUbiquitin-Protein LigasesZincAMPK-Mfn2MitophagymPTPResveratrolZinc deficiency

Identifiers

PMID37458914
OpenAlexW4384525011

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.